Levetiracetam (Redilev)
Levetiracetam
Dr Reddyæs Laboratories (Pty) Ltd
Registration
- Applicant
- Dr Reddyæs Laboratories (Pty) Ltd
- Certificate holder
- Dr. Reddy’s Laboratories (Pty) Ltd.
- Registrations
- 3
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Redilev 250 EACH TABLET CONTAINS LEVETIRACETAM 250,0 mg | 250Tablets | 41046041/2.5/0460Approved 25 November 2016 | Registered | S3 | PIPIL |
| Redilev 500 EACH TABLET CONTAINS LEVETIRACETAM 500,0 mg | 500Tablets | 41046141/2.5/0461Approved 25 November 2016 | Registered | S3 | PIPIL |
| Redilev 750 EACH TABLET CONTAINS LEVETIRACETAM 750,0 mg | 750Tablets | 41046241/2.5/0462Approved 25 November 2016 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Levetiracetam
S3: Levetiracetam
Consolidated Schedules 06 July 2026, line 3890
Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S)-2-(2-Oxopyrrolidin-1-yl)butanamide
Drag to rotate. Structure from PubChem CID 5284583.
SAHPRA documents
Schedule Verification
This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.